![IFN-III is selectively produced by cDC1 and predicts good clinical outcome in breast cancer | Science Immunology IFN-III is selectively produced by cDC1 and predicts good clinical outcome in breast cancer | Science Immunology](https://www.science.org/cms/10.1126/sciimmunol.aav3942/asset/a816b2b8-3b50-4382-9593-7ddd9f457f5e/assets/graphic/aav3942-f1.jpeg)
IFN-III is selectively produced by cDC1 and predicts good clinical outcome in breast cancer | Science Immunology
![JPM | Free Full-Text | NTRK Gene Fusions in Solid Tumors and TRK Inhibitors: A Systematic Review of Case Reports and Case Series JPM | Free Full-Text | NTRK Gene Fusions in Solid Tumors and TRK Inhibitors: A Systematic Review of Case Reports and Case Series](https://pub.mdpi-res.com/jpm/jpm-12-01819/article_deploy/html/images/jpm-12-01819-ag.png?1667643911)
JPM | Free Full-Text | NTRK Gene Fusions in Solid Tumors and TRK Inhibitors: A Systematic Review of Case Reports and Case Series
![Epstein–Barr virus-associated lymphomas | Philosophical Transactions of the Royal Society B: Biological Sciences Epstein–Barr virus-associated lymphomas | Philosophical Transactions of the Royal Society B: Biological Sciences](https://royalsocietypublishing.org/cms/asset/7ff7300f-b8a4-43f0-9ac4-74a508e2d069/rstb.372.issue-1732.largecover.jpeg)
Epstein–Barr virus-associated lymphomas | Philosophical Transactions of the Royal Society B: Biological Sciences
![Cancers | Free Full-Text | A Gold Nanoparticle Bioconjugate Delivery System for Active Targeted Photodynamic Therapy of Cancer and Cancer Stem Cells Cancers | Free Full-Text | A Gold Nanoparticle Bioconjugate Delivery System for Active Targeted Photodynamic Therapy of Cancer and Cancer Stem Cells](https://www.mdpi.com/cancers/cancers-14-04558/article_deploy/html/images/cancers-14-04558-g001-550.jpg)
Cancers | Free Full-Text | A Gold Nanoparticle Bioconjugate Delivery System for Active Targeted Photodynamic Therapy of Cancer and Cancer Stem Cells
![IFN-III is selectively produced by cDC1 and predicts good clinical outcome in breast cancer | Science Immunology IFN-III is selectively produced by cDC1 and predicts good clinical outcome in breast cancer | Science Immunology](https://www.science.org/cms/10.1126/sciimmunol.aav3942/asset/88282133-31f0-4870-8527-5149029af535/assets/graphic/aav3942-f2.jpeg)
IFN-III is selectively produced by cDC1 and predicts good clinical outcome in breast cancer | Science Immunology
![Christopher CHIEN | Biologist | PhD | U.S. Department of Health and Human Services, MD | HHS | National Cancer Institute | Research profile Christopher CHIEN | Biologist | PhD | U.S. Department of Health and Human Services, MD | HHS | National Cancer Institute | Research profile](https://i1.rgstatic.net/ii/profile.image/404070566252547-1473349338394_Q512/Christopher-Chien-3.jpg)
Christopher CHIEN | Biologist | PhD | U.S. Department of Health and Human Services, MD | HHS | National Cancer Institute | Research profile
![Cancers | Free Full-Text | Application of In Vivo Imaging Techniques for Monitoring Natural Killer Cell Migration and Tumor Infiltration Cancers | Free Full-Text | Application of In Vivo Imaging Techniques for Monitoring Natural Killer Cell Migration and Tumor Infiltration](https://pub.mdpi-res.com/cancers/cancers-12-01318/article_deploy/html/images/cancers-12-01318-g001.png?1591375839)
Cancers | Free Full-Text | Application of In Vivo Imaging Techniques for Monitoring Natural Killer Cell Migration and Tumor Infiltration
![Strategies to enhance immunomodulatory properties and reduce heterogeneity in mesenchymal stromal cells during ex vivo expansion - Cytotherapy Strategies to enhance immunomodulatory properties and reduce heterogeneity in mesenchymal stromal cells during ex vivo expansion - Cytotherapy](https://www.isct-cytotherapy.org/cms/attachment/b3e2f362-b367-4c7b-9fd5-b3c8bece7d35/gr1_lrg.jpg)